AZD-1480 - CAS# 935666-88-9 321 Smiles: CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N)C1CC(C1)CCC1NC2=CC=C(C=C2N=1)C(C)(C)C

Smiles: CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N)C1CC(C1)CCC1NC2=CC=C(C=C2N=1)C(C)(C)C

It can serve as a very useful reagent to enhance the safety of hPSC-based treatments and facilitate safe transplantation of larger cell numbers

Suppression of immunodominant antitumor and antiviral CD8+ T cell responses by indoleamine 2

Kartogenin (KGN)

AZD-1480 - CAS# 935666-88-9 321 Smiles: CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N)C1CC(C1)CCC1NC2=CC=C(C=C2N=1)C(C)(C)CAZD1480. CAS# 935666 88 9, is an orally bioavailable inhibitor of Janus associated kinase 2 (JAK2) with potential antineoplastic activity. JAK2 inhibitor AZD1480 inhibits JAK2 activation, leading to the inhibition of the JAK STAT (signal transducer and activator of transcription) signaling including activation of STAT3. This may lead to induction of tumor cell apoptosis and a decrease in cellular proliferation. JAK2, often upregulated or mutated in a